Pruritus in cholestatic liver diseases can be a major burden and dramatically impair the
quality of life of those affected. Here, we provide an update on the latest insights into the …

Diagnosis of autoimmune diseases is in most cases challenging for clinicians as there is not
a single specific laboratory or histological marker to diagnose or exclude the presence of the …

This is the second European Crohn's and Colitis Organisation [ECCO] evidence-based
consensus on extraintestinal manifestations [EIMs] of inflammatory bowel disease [IBD] and …

Liver diseases in pregnancy comprise both gestational liver disorders and acute and chronic
hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or …

Itaconate inhibits CD103+ TRM cells and alleviates hepatobil... : Hepatology Itaconate inhibits
CD103+ TRM cells and alleviates hepatobiliary injury in mouse models of primary sclerosing …

Gastrointestinal endoscopy has always formed a reliable and indispensable backbone in
the diagnosis and management of hepatobilary disorders and their complications. However …

Cholangiocarcinoma remains an aggressive and deadly malignancy that is often diagnosed
late. Intrinsic tumour characteristics and the growth pattern of cancer cells contribute to the …

Primary sclerosing cholangitis (PSC) was declared one of the biggest unmet needs in
hepatology during ILC 2016 in Berlin. Since then, not much has changed unfortunately …

Simple Summary Hepatocellular cancer and biliary tract cancers are associated with poor
prognosis, particularly in advanced stages. However, early diagnosis offers the potential for …

Abstract IgG4-related cholangitis (IRC) is the major hepatobiliary manifestation of IgG4-
related disease (IgG4-RD), a systemic fibroinflammatory disorder. The pathogenesis of IgG4 …